Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00508443 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Oct 31, 2026 → Oct 31, 2028
See other at-risk trials from M.D. Anderson Cancer Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Oct 31, 2026 to Oct 31, 2028
    • Eligibility criteria expanded, about 19 words
    • Publications: details revised at 2 of 2 entries
  2. 4 versions Re-verified since Jan 8, 2025, no change to tracked fieldsv28-v31
  3. Primary and study completion dates: Oct 31, 2024 to Oct 31, 2026v27
  4. Re-verified, no change to tracked fieldsv26
  5. Primary and study completion dates: Oct 31, 2022 to Oct 31, 2024v25
Show 23 earlier versionsHide 23 earlier versions
  1. Re-verified, no change to tracked fieldsv24
  2. Primary and study completion dates: Oct 31, 2021 to Oct 31, 2022v23
  3. Primary and study completion dates: Oct 31, 2020 to Oct 31, 2021v22
  4. Primary completion date: Oct 2019 to Oct 31, 2020
    • Study completion date: Oct 2020 to Oct 31, 2020
    • Start date: Oct 2002 to Oct 25, 2002
    v21
  5. Re-verified, no change to tracked fieldsv20
  6. Primary completion date: Oct 2018 to Oct 2019
    • Study completion date: Oct 2018 to Oct 2020
    v19
  7. Primary completion date: Oct 2017 to Oct 2018
    • Study completion date: Oct 2018
    v18
  8. Primary completion date: Oct 2016 to Oct 2017v17
  9. Primary completion date: Oct 2015 to Oct 2016
    • Study site revised
    v16
  10. Primary completion date: Oct 2014 to Oct 2015v15
  11. Primary completion date: Oct 2013 to Oct 2014v14
  12. Primary completion date: Oct 2012 to Oct 2013
    • Eligibility criteria shortened, about 4 words
    • Study description shortened, about 3 words
    v13
  13. Re-verified, no change to tracked fieldsv12
  14. Primary completion date: Oct 2011 to Oct 2012v11
  15. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  16. Eligibility criteria expanded, about 4 wordsv9
  17. Study site revisedv8
  18. Primary completion date: Oct 2010 to Oct 2011v7
  19. Primary endpoint revised
    • Eligibility criteria revised
    • Secondary endpoints shortened, about 27 words
    v6
  20. Primary completion date: Oct 2009 to Oct 2010
    • Secondary endpoints: details revised at 2 of 2 entries
    v5
  21. Eligibility criteria revised
    • Study description expanded, about 3 words
    v4
  22. Primary endpoint revised
    • Secondary endpoints revised (2)
    • Study description expanded, about 1 word
    v3
  23. Primary completion date: Oct 2009
    • Interventions: Stereotactic Spine Radiotherapy (Procedure) to Radiation Therapy (Radiation)
    • Study arms: 0 to 1
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
M.D. Anderson Cancer Center
1,230 trials monitored
See 92 trials at risk
Breast Cancer
5,418 trials monitored
See 296 trials at risk
Lung Cancer
4,790 trials monitored
See 263 trials at risk
Melanoma
1,092 trials monitored
See 60 trials at risk
and 1 more disease
The goal of this clinical research study is to find out if stereotactic spine radiotherapy is safe and effective in the treatment of metastatic spine tumors. The feasibility of this type of treatment will be studied as will any side effects related to the treatment. The precision and accuracy of the CT-on-rails will also be studied.
Trial Details
NCT Number NCT00508443
Lead Sponsor M.D. Anderson Cancer Center
Conditions
(from sponsor)		 Spinal Neoplasms
Related terms Breast Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Neoplasms, Sarcoma, Spinal Diseases, Spinal Neoplasms, Urogenital Diseases
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov